BCO vs SRPT
Brinks Company (BCO) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Brinks Company (BCO) is a security & protection services company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported BCO revenue for 2024-12-31 was $5.01B. Net income was $174.7M. Revenue was up 2.8% from 2023-12-31 to 2024-12-31. BCO currently screens at market cap $3.97B and trailing P/E 25.4.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
BCO currently screens at market cap $3.97B and trailing P/E 25.4. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the BCO and SRPT stock pages for the full models.
Not investment advice.